文献速递头颈外科

头颈癌患者限时100 mL饮水试验:何为有临床意义的差异

The timed 100 mL water swallow test for patients with head and neck cancer: What constitutes a clinically significant difference?
PubMed 文献 · Head Neck · 2024-07-24

本研究纳入211例接受单一或联合方式治疗的头颈癌(HNC)患者,在基线(治疗前)和治疗后12个月完成100 mL饮水试验(100 mL WST)与M.D. Anderson吞咽障碍量表(MDADI)。采用锚定法(以MDADI为锚,含平均变化和ROC曲线)和分布法(半标准差法)计算最小临床重要差异(MCID)。结果显示,恶化MCID为4 mL/s(灵敏度75%,1-特异度46%),改善MCID为5 mL/s(基于分布法)。

要点

  • 恶化MCID为4 mL/s,灵敏度75%,1-特异度46%。
  • 改善MCID为5 mL/s,基于分布法(半标准差法)得出。
  • 作者认为在临床实践和临床试验中可增加100 mL WST的使用。

核心结论

  • 从基线至头颈癌治疗后12个月,100 mL WST恶化4 mL/s或增加5 mL/s,从患者角度相当于MCID。
  • 作者认为,基于这些发现,在临床实践中增加100 mL WST的使用以观察变化、在临床试验中解释和比较不同研究组可能是有益的。

研究设计与样本

  • 纳入211例接受单一或联合方式治疗的头颈癌患者。
  • 在基线(治疗前)和治疗后12个月完成100 mL WST与MDADI。
  • 采用锚定法(以MDADI为锚,含平均变化和ROC曲线)和分布法(半标准差法)计算MCID。

主要发现

  • 锚定法中,100 mL WST的4 mL/s被定义为恶化的MCID,灵敏度75%,1-特异度46%。
  • 分布法得出5 mL/s为改善的MCID。
  • 恶化4 mL/s或较基线增加5 mL/s(至治疗后12个月)相当于MCID。

关键数值与推荐

  • 恶化MCID:4 mL/s(锚定法;灵敏度75%,1-特异度46%)。
  • 改善MCID:5 mL/s(分布法,半标准差法)。

临床怎么用

  • 作者认为在临床实践中可增加100 mL WST的使用以观察变化。
  • 作者认为在临床试验中可用100 mL WST解释和比较不同研究组。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Swallowing function in patients with head and neck cancer (HNC) is often assessed pre-treatment, during and at intervals post-treatment to identify those with dysphagia as early as possible. This study aims to investigate the minimal clinical important difference (MCID) for the 100 mL water swallow test (100 mL WST) to increase its utility in clinical practice and in clinical trials. METHODS: Data from 211 HNC patients, treated by either single or combined modality were included. Patients completed both the 100 mL WST and M.D. Anderson Dysphagia Inventory (MDADI) at baseline (i.e., prior to treatment) and 12 months post-treatment. The MCID for the 100 mL WST was calculated using two approaches of the anchor-based method (using the MDADI), including mean change, and ROC curve. Additionally, the distribution-based method was used utilizing the half standard deviation approach. RESULTS: In the anchor-based method, a 4 mL/s in the 100 mL WST was defined as an MCID for deterioration, with a sensitivity of 75% and a 1-specificity of 46%. In contrast, a change of 5 mL/s was deemed as an MCID for improvement, based on the distribution-based method. CONCLUSION: The findings showed that deterioration of 4 mL, or an increase of 5 mL from baseline to 12 months post-HNC treatment equates to an MCID from the patients' perspective. Based on these findings, it may be beneficial to increase the utilization of the 100 mL WST in clinical practice to observe the changes, and in clinical trials to interpret and compare different study arms.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Altamimi JA, Wilson JA, Roe J, et al. The timed 100 mL water swallow test for patients with head and neck cancer: What constitutes a clinically significant difference? Head Neck. 2024. PMID: 39046025. doi:10.1002/hed.27885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。